BGI Genomics Co Ltd (300676) — Capital Reinvestment Ratio
Latest as of December 2024:
0.69x
BGI Genomics Co Ltd (300676) has a Capital Reinvestment Ratio of 0.69x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥238.54 Million) in capital expenditures (CN¥165.34 Million). See how much free cash does BGI Genomics Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.69x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥238.54 Million
CNY
Capital Expenditures
CN¥165.34 Million
CNY
Data as of
Dec 2024
Most recent filing
BGI Genomics Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks BGI Genomics Co Ltd's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for BGI Genomics Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for BGI Genomics Co Ltd from 2012 to 2024. For live market cap and broader valuation context, see market cap of BGI Genomics Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 5.53x | CN¥95.72 Million | CN¥529.48 Million | ▲ +82.9% |
| 2023 | 3.02x | CN¥408.77 Million | CN¥1.24 Billion | ▼ -68.7% |
| 2022 | 9.68x | CN¥130.88 Million | CN¥1.27 Billion | ▲ +6148.1% |
| 2021 | 0.15x | CN¥2.48 Billion | CN¥383.52 Million | ▲ +85.3% |
| 2020 | 0.08x | CN¥3.60 Billion | CN¥301.15 Million | ▼ -97.0% |
| 2019 | 2.79x | CN¥224.25 Million | CN¥626.44 Million | ▼ -93.9% |
| 2018 | 46.17x | CN¥14.69 Million | CN¥678.13 Million | ▲ +3761.6% |
| 2017 | 1.20x | CN¥243.66 Million | CN¥291.33 Million | ▲ +13.8% |
| 2016 | 1.05x | CN¥234.07 Million | CN¥246.01 Million | ▲ +94.9% |
| 2015 | 0.54x | CN¥328.68 Million | CN¥177.26 Million | ▼ -93.1% |
| 2013 | 7.76x | CN¥36.70 Million | CN¥284.88 Million | ▲ +809.1% |
| 2012 | 0.85x | CN¥72.49 Million | CN¥61.89 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow